These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 15367052

  • 1. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
    Misri S, Reebye P, Corral M, Milis L.
    J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
    [Abstract] [Full Text] [Related]

  • 2. Reexamining paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety.
    McClendon J.
    J Clin Psychiatry; 2005 Nov; 66(11):1494-5; author reply 1495. PubMed ID: 16420094
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine.
    Spinhoven P, Van der Does AJ, Van Dijk E, Van Rood YR.
    J Psychosom Res; 2010 Sep; 69(3):227-35. PubMed ID: 20708444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM, Gao KR, Yu H, Shen YF, Li HF.
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [Abstract] [Full Text] [Related]

  • 11. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R.
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
    Rickels K, Rynn M, Iyengar M, Duff D.
    J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Internet and Face-to-face Cognitive Behavioral Therapy for Postnatal Depression Compared With Treatment as Usual: Randomized Controlled Trial of MumMoodBooster.
    Milgrom J, Danaher BG, Seeley JR, Holt CJ, Holt C, Ericksen J, Tyler MS, Gau JM, Gemmill AW.
    J Med Internet Res; 2021 Dec 08; 23(12):e17185. PubMed ID: 34889742
    [Abstract] [Full Text] [Related]

  • 18. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW.
    J Clin Psychiatry; 2005 Jan 08; 66(1):94-9. PubMed ID: 15669894
    [Abstract] [Full Text] [Related]

  • 19. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC, Rengasamy M, Mansoor B, He J, Mayes T, Emslie GJ, Porta G, Clarke GN, Wagner KD, Birmaher B, Keller MB, Ryan N, Shamseddeen W, Asarnow JR, Brent DA.
    J Am Acad Child Adolesc Psychiatry; 2013 May 08; 52(5):482-92. PubMed ID: 23622849
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.
    J Clin Psychiatry; 1997 Mar 08; 58(3):112-8. PubMed ID: 9108813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.